STOCK TITAN

Teladoc Health to Acquire Catapult Health, Advancing Integrated Care Strategy

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)

Teladoc Health (NYSE: TDOC) has announced a definitive agreement to acquire Catapult Health for $65 million in cash, with an additional $5 million potential earnout. The acquisition aims to enhance Teladoc's preventive care and chronic care management capabilities through Catapult's VirtualCheckup program, which provides at-home diagnostic testing and virtual nurse practitioner consultations.

Catapult Health generated approximately $30 million in trailing twelve-month revenue as of Q3 2024 and serves hundreds of employers with over three million covered lives. The company's VirtualCheckup service has demonstrated strong results, including an 81+ Net Promoter Score and significant health impact, with 30% of members discovering high blood pressure and 28% learning of prediabetes for the first time.

The acquisition, expected to close in Q1 2025, aligns with Teladoc's integrated care strategy focusing on membership growth, healthcare outcomes improvement, international expansion, and mental health services advancement.

Teladoc Health (NYSE: TDOC) ha annunciato un accordo definitivo per acquisire Catapult Health per 65 milioni di dollari in contante, con un ulteriore potenziale guadagno di 5 milioni di dollari. L'acquisizione mira a migliorare le capacità di Teladoc nella cura preventiva e nella gestione delle malattie croniche attraverso il programma VirtualCheckup di Catapult, che offre test diagnostici a domicilio e consultazioni virtuali con infermieri specialisti.

Catapult Health ha generato circa 30 milioni di dollari di fatturato nell'anno fiscale precedente fino al terzo trimestre del 2024 e serve centinaia di datori di lavoro con oltre tre milioni di vite coperte. Il servizio VirtualCheckup della compagnia ha mostrato risultati notevoli, inclusi un punteggio Net Promoter superiore a 81 e un impatto significativo sulla salute, con il 30% dei membri che ha scoperto di avere la pressione alta e il 28% che ha appreso di essere prediabetico per la prima volta.

L'acquisizione, prevista per concludersi nel primo trimestre del 2025, si allinea con la strategia di assistenza integrata di Teladoc, che si concentra sulla crescita dell'adesione, sul miglioramento dei risultati sanitari, sull'espansione internazionale e sull'avanzamento dei servizi di salute mentale.

Teladoc Health (NYSE: TDOC) ha anunciado un acuerdo definitivo para adquirir Catapult Health por 65 millones de dólares en efectivo, con un adicional de 5 millones de dólares como posible ganancia. La adquisición tiene como objetivo mejorar las capacidades de Teladoc en la atención preventiva y la gestión de enfermedades crónicas a través del programa VirtualCheckup de Catapult, que proporciona pruebas diagnósticas a domicilio y consultas virtuales con enfermeras practicantes.

Catapult Health generó aproximadamente 30 millones de dólares en ingresos durante los últimos doce meses hasta el tercer trimestre de 2024 y atiende a cientos de empleadores con más de tres millones de vidas aseguradas. El servicio VirtualCheckup de la compañía ha demostrado resultados sólidos, incluidos más de 81 puntos en el Net Promoter Score y un impacto significativo en la salud, con el 30% de los miembros descubriendo que tienen presión arterial alta y el 28% aprendiendo que son prediabéticos por primera vez.

Se espera que la adquisición se complete en el primer trimestre de 2025, y se alinea con la estrategia de atención integrada de Teladoc, que se centra en el crecimiento de la membresía, la mejora de los resultados de salud, la expansión internacional y el avance de los servicios de salud mental.

Teladoc Health (NYSE: TDOC)Catapult Health를 현금 6,500만 달러에 인수하기 위한 최종 계약을 발표했으며, 추가로 500만 달러의 잠재적 수익이 있습니다. 이번 인수는 Catapult의 VirtualCheckup 프로그램을 통해 Teladoc의 예방 의료 및 만성 질환 관리 능력을 향상시키는 것을 목표로 하며, 이는 가정에서의 진단 테스트 및 가상 간호사 상담을 제공합니다.

Catapult Health는 2024년 3분기 기준으로 지난 12개월 동안 약 3천만 달러의 매출을 올렸으며, 300만 명 이상의 보장된 생명을 가진 수백 개의 고용주를 대상으로 서비스를 제공합니다. 이 회사의 VirtualCheckup 서비스는 81점 이상의 넷 프로모터 점수를 포함하여 강력한 결과를 보여주었으며, 회원의 30%가 고혈압을 발견하고 28%가 처음으로 당뇨병 전 단계인 것을 알게 되었습니다.

2025년 1분기에 마감될 것으로 예상되는 이번 인수는 Teladoc의 통합 치료 전략과 일치하며, 이는 회원 성장, 건강 결과 개선, 국제 확장 및 정신 건강 서비스 발전에 초점을 맞추고 있습니다.

Teladoc Health (NYSE: TDOC) a annoncé un accord définitif pour acquérir Catapult Health pour 65 millions de dollars en espèces, avec un potentiel de 5 millions de dollars supplémentaires sous forme de primes. L'acquisition vise à améliorer les capacités de Teladoc en matière de soins préventifs et de gestion des maladies chroniques grâce au programme VirtualCheckup de Catapult, qui propose des tests diagnostics à domicile et des consultations virtuelles avec des infirmiers praticiens.

Catapult Health a généré environ 30 millions de dollars de revenus au cours des douze derniers mois jusqu'au troisième trimestre 2024 et sert des centaines d'employeurs avec plus de trois millions de vies couvertes. Le service VirtualCheckup de l'entreprise a démontré des résultats solides, y compris un score Net Promoter supérieur à 81 et un impact significatif sur la santé, avec 30 % des membres découvrant une hypertension et 28 % apprenant pour la première fois qu'ils sont en prédiabète.

L'acquisition, qui devrait se conclure au premier trimestre 2025, s'inscrit dans la stratégie de soins intégrés de Teladoc, axée sur la croissance des adhésions, l'amélioration des résultats de santé, l'expansion internationale et l'avancement des services de santé mentale.

Teladoc Health (NYSE: TDOC) hat eine endgültige Vereinbarung zur Übernahme von Catapult Health für 65 Millionen US-Dollar in bar bekannt gegeben, mit einem zusätzlichen potentiellen Earnout von 5 Millionen US-Dollar. Die Übernahme zielt darauf ab, die Präventiv- und chronische Pflege-Management-Fähigkeiten von Teladoc durch das VirtualCheckup-Programm von Catapult zu verbessern, das diagnostische Tests zu Hause und virtuelle Beratungen mit Pflegeberatern anbietet.

Catapult Health erzielte im Zeitraum von zwölf Monaten bis Q3 2024 einen Umsatz von etwa 30 Millionen US-Dollar und betreut Hunderte von Arbeitgebern mit über drei Millionen versicherten Leben. Der VirtualCheckup-Service des Unternehmens hat starke Ergebnisse gezeigt, darunter einen Net Promoter Score von über 81 und einen signifikanten Gesundheitseffekt, wobei 30 % der Mitglieder einen hohen Blutdruck entdeckten und 28 % zum ersten Mal von einer Prädiabetes erfuhren.

Die Übernahme, die voraussichtlich im ersten Quartal 2025 abgeschlossen wird, passt zur integrierten Versorgungsstrategie von Teladoc, die sich auf Mitgliederwachstum, Verbesserung der Gesundheits-Ergebnisse, internationale Expansion und Fortschritte bei den Dienstleistungen im Bereich psychische Gesundheit konzentriert.

Positive
  • All-cash acquisition valued at $65M with potential $5M earnout
  • Catapult Health's trailing twelve-month revenue of $30M
  • Strong customer satisfaction with 81+ Net Promoter Score
  • Demonstrated cost savings of $1,400 per member over 3 years
  • Access to additional 3 million covered lives
  • Integration with existing chronic care management programs
Negative
  • Purchase price represents approximately 2.2x revenue multiple

Insights

This strategic acquisition represents a calculated move by Teladoc to strengthen its position in the preventive care space at a reasonable valuation of 2.2x revenue. The deal structure, combining $65M upfront with a $5M performance-based earnout, demonstrates prudent financial management while ensuring alignment with Catapult's team.

The acquisition's value proposition is compelling on multiple fronts:

  • Catapult's proven ROI metrics showing $1,400 cost savings per member over 3 years provides a clear path to customer adoption and retention
  • The high NPS score of 81+ indicates strong product-market fit and customer satisfaction
  • Early detection rates of 30% for high blood pressure and 28% for prediabetes demonstrate significant clinical value

The integration of Catapult's capabilities into Teladoc's existing infrastructure creates meaningful cross-selling opportunities across their 93-million-member base. The ability to directly enroll members into Teladoc's chronic care management programs should accelerate revenue growth while reducing customer acquisition costs. This vertical integration strategy could significantly enhance Teladoc's competitive moat in the virtual care space.

This acquisition significantly advances Teladoc's technological capabilities in three critical areas:

  • At-home diagnostics integration: VirtualCheckup's proven platform for blood sampling and vital sign monitoring fills a important gap in Teladoc's virtual care ecosystem
  • Care pathway automation: The seamless enrollment system for chronic condition management programs reduces friction in patient care journeys
  • Data-driven care coordination: Lab-confirmed A1c values enable more precise population health management and care gap closure

The technology stack integration presents an opportunity to create a more cohesive virtual care experience, potentially increasing engagement rates and improving clinical outcomes. The ability to combine Catapult's preventive care data with Teladoc's existing patient information could enhance risk stratification and early intervention capabilities, leading to more personalized care delivery.

Strategic acquisition will enhance Teladoc Health’s preventive care and chronic care management capabilities, expand at-home testing

PURCHASE, NY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that it has signed a definitive agreement to acquire Catapult Health, a leading provider of virtual preventive care services. The company plans to leverage Catapult Health’s innovative approach to patient-centric at-home diagnostic testing, as well as its high-touch engagement and clinical support model, to complement Teladoc Health’s industry-leading suite of integrated solutions.

Building on its over 93-million-member base, Teladoc Health’s acquisition of Catapult Health supports the company’s integrated care segment strategy, discussed most recently during the company’s presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The strategy focuses on four key objectives: grow membership and use of services; leverage clinical strength and product breadth to deepen the impact on healthcare outcomes; expand its international business; and advance its scaled mental health position. The Catapult Health acquisition specifically seeks to advance efforts to improve early detection of health conditions, connect Teladoc Health’s members with high-quality care and deliver better health outcomes in care management.

“Catapult Health’s capabilities will help advance our strategy in meaningful ways — from giving more members access to convenient and impactful wellness and preventative care, to unlocking greater value for our customers,” said Chuck Divita, Chief Executive Officer of Teladoc Health. “Catapult Health brings an experienced team and a strong culture of innovation, and we are thrilled to welcome them to Teladoc Health.”

With Catapult Health’s innovative at-home wellness exam, VirtualCheckup, members receive a simple kit with everything they need to collect a blood sample, check blood pressure, and provide other health screening information, followed by a virtual visit with a licensed nurse practitioner to discuss test results, review key health risks, and create a personalized health action plan.

When Catapult Health’s members are assessed with conditions or high-risk factors that require a health action plan, Catapult Health’s clinicians will be able to directly enroll eligible members into Teladoc Health’s diabetes, hypertension, pre-diabetes and weight management programs, and seamlessly refer them to Teladoc’s virtual mental health therapists and primary care providers.

The company will also use Catapult Health’s technology to support new product enhancements, such as providing customers with lab-confirmed A1c values on which to base population enrollment and close gaps in care.

“For over a decade, we’ve been helping customers improve health outcomes and bend the cost curve,” said David Michel, Chief Executive Officer of Catapult Health. “Joining forces with Teladoc Health will help us accelerate our impact and advance our shared mission to empower healthier lives.”

Key Facts
Teladoc Health has signed a definitive agreement to acquire Catapult Health in an all-cash transaction for $65 million, with up to $5 million in additional contingent earnout consideration. Catapult Health’s trailing twelve-month revenue was approximately $30 million as of the third quarter of 2024. The transaction is expected to close in the first quarter of 2025, subject to customary closing conditions.

Following the closing of the transaction, Catapult Health will operate within the Integrated Care segment of Teladoc Health.

With hundreds of employer customers and more than three million covered lives, Catapult Health is recognized for its strong customer satisfaction, clinical outcomes, and cost savings. Catapult Health members consistently praise the VirtualCheckup experience, reflected in an impressive 81+ Net Promoter Score (NPS). The checkup has shown demonstrable results in the early detection of diseases and health risks, with 30% of members discovering high blood pressure and 28% learning they have prediabetes for the first time. Employers and health plans recognize Catapult Health’s clinical value, supported by an independent analysis by a third-party health plan confirming that the Catapult Health VirtualCheckup delivers more than $1,400 of cost savings over a 3-year period.

About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, the potential transaction between Teladoc Health and Catapult, including any statements regarding the expected timetable for completing the potential transaction, the ability to complete the potential transaction, the expected effects of the potential transaction (including projected financial information and future opportunities) and any other statements regarding Teladoc Health’s and Catapult’s future expectations. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, uncertainties as to the timing to consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; the risk that any regulatory approvals are not obtained or are obtained subject to conditions that are not anticipated by the parties; potential litigation relating to the potential transaction that could be instituted against Teladoc Health, Catapult or their respective directors; the effects of disruption to Teladoc Health’s or Catapult’s respective businesses; restrictions during the pendency of the potential transaction that may impact Teladoc Health’s or Catapult’s ability to pursue certain business opportunities or strategic transactions; the effect of this communication on Teladoc Health’s stock price; transaction costs; Teladoc Health’s ability to achieve the benefits from the proposed transaction; Teladoc Health’s ability to effectively integrate acquired operations into its own operations; the ability of Teladoc Health or Catapult to retain and hire key personnel; unknown liabilities; and the diversion of management time on transaction-related issues. Other important factors that could cause actual results to differ materially from those in the forward-looking statements include: (i) changes in laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings, including our ability to effectively compete; (iii) results of litigation or regulatory actions; (iv) the loss of one or more key clients or the loss of a significant number of members or BetterHelp paying users; (v) changes in valuations or useful lives of our assets; (vi) changes to our abilities to recruit and retain qualified providers into our network; (vii) the impact of and risk related to impairment losses with respect to goodwill or other assets; and (viii) the success of our operational review of the company to achieve a more balanced approach to growth and margin. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Media:
Lou Serio
PR@teladochealth.com

Investors:
Michael Minchak
IR@teladochealth.com

Photos accompanying this announcement are available at: 
https://www.globenewswire.com/NewsRoom/AttachmentNg/f3d83c20-3d03-4e73-a1fa-5689b78df61d

https://www.globenewswire.com/NewsRoom/AttachmentNg/668c1401-5f4b-4b52-a73e-d6e3af303559


FAQ

What is the acquisition price for Catapult Health by TDOC?

Teladoc Health (TDOC) is acquiring Catapult Health for $65 million in an all-cash transaction, with potential additional earnout of up to $5 million.

What is Catapult Health's revenue prior to TDOC acquisition?

Catapult Health's trailing twelve-month revenue was approximately $30 million as of the third quarter of 2024.

When will TDOC complete the Catapult Health acquisition?

The transaction is expected to close in the first quarter of 2025, subject to customary closing conditions.

What are the key benefits of Catapult Health's VirtualCheckup program?

VirtualCheckup has shown that 30% of members discover high blood pressure and 28% learn they have prediabetes for the first time, with demonstrated cost savings of over $1,400 per member over a 3-year period.

How many covered lives does Catapult Health bring to TDOC?

Catapult Health brings more than three million covered lives across hundreds of employer customers to Teladoc Health.

Teladoc Health, Inc.

NYSE:TDOC

TDOC Rankings

TDOC Latest News

TDOC Stock Data

1.81B
168.52M
0.82%
76.45%
13.65%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
PURCHASE